[HTML][HTML] Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert, J Bosschieter, PC Kauer… - Clinical …, 2022 - Springer
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
AE Hentschel, IJ Beijert, J Bosschieter, PC Kauer… - Clinical …, 2022 - go.gale.com
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert… - Clinical …, 2022 - researchinformation.amsterdamumc …
Background: The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert, J Bosschieter… - Clinical …, 2022 - search.proquest.com
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
[HTML][HTML] Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert, J Bosschieter… - Clinical …, 2022 - ncbi.nlm.nih.gov
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
AE Hentschel, IJ Beijert, J Bosschieter… - Clinical …, 2022 - search.ebscohost.com
Background: The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert, J Bosschieter… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
[HTML][HTML] Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert… - Clinical …, 2022 - clinicalepigeneticsjournal …
The development of accurate urinary biomarkers for non-invasive and cost-effective
detection of primary and recurrent bladder tumours is recognized as one of the major clinical …
detection of primary and recurrent bladder tumours is recognized as one of the major clinical …
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
AE Hentschel, IJ Beijert, J Bosschieter… - Clinical …, 2022 - europepmc.org
Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …
[PDF][PDF] Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
AE Hentschel, IJ Beijert, J Bosschieter… - 2022 - clinicalepigeneticsjournal …
Background: The development of accurate urinary biomarkers for non‑invasive and cost‑
effective detection of primary and recurrent bladder tumours is recognized as one of the …
effective detection of primary and recurrent bladder tumours is recognized as one of the …